Drug
Delavirdine clinical trials
How studies write it
Studies that test it under each name
Name
- Delavirdine mesylate
- 13
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 5
Pharmacia and Upjohn (7) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Boehringer Ingelheim (1) · Bristol-Myers Squibb (1)
Often tested with
Tested in the same studies.
Zidovudine (7) · Didanosine (4) · Lamivudine (4) · Indinavir (4) · Nelfinavir (3) · Stavudine (3) · Saquinavir (2) · Ritonavir (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Delavirdine is read from its arms, and is right about nine times in ten.
Testing it · 14
- A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000892Written as Delavirdine mesylate
- Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)CompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000810Written as Delavirdine mesylate
- A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination TherapyCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000803Written as Delavirdine mesylate
- A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected PatientsWithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001094Written as Delavirdine mesylate
- Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without TipranavirCompletedPhase 2Boehringer IngelheimNCT02249130Written as Delavirdine (DLV)
- Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000882Written as Delavirdine mesylate
- The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsTerminatedPhase 2Bristol-Myers SquibbNCT00002420Written as Delavirdine mesylate
- A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNot applicablePharmacia and UpjohnNCT00002401Written as Delavirdine mesylate
- A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3CompletedPhase 3Pharmacia and UpjohnNCT00002124Written as Delavirdine mesylate
- A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and BabiesCompletedPhase 2Pharmacia and UpjohnNCT00002210Written as Delavirdine mesylate
- A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3CompletedPhase 3Pharmacia and UpjohnNCT00002123Written as Delavirdine mesylate
- A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive PatientsCompletedNot applicablePharmacia and UpjohnNCT00002236Written as Delavirdine mesylate
- A Study of Two Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNot applicablePharmacia and UpjohnNCT00002400Written as Delavirdine mesylate
- Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected PatientsCompletedNot applicablePharmacia and UpjohnNCT00002211Written as Delavirdine mesylate
Codes
What other systems call Delavirdine · ClinicalTrials.gg INT008743
- MeSH (NLM) D020008DelavirdineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) DOL5F9JD3EDELAVIRDINEConfirmed FDA, NLM, Wikidata
- RxNorm 83816Confirmed FDA, Wikidata
- Wikidata Q370244delavirdineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65366DelavirdineOne source FDA
- DrugBank DB00705One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020008 | Delavirdine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | DOL5F9JD3E | DELAVIRDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 83816 | — | Confirmed FDA, Wikidata |
| Wikidata | Q370244 | delavirdine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65366 | Delavirdine | One source FDA |
| DrugBank | DB00705 | — | One source Wikidata |
Also registered as delavirdine mesylate (UNII 421105KRQE · RxNorm 142152).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.